NHS Blocks Private ADHD Diagnoses: Patients Denied Medication

NHS doctors are currently refusing to prescribe ADHD medication for individuals who received their diagnoses from private clinics. This situation arises because many patients have turned to private providers due to extensive NHS waiting lists, with some areas suspending new referrals entirely.

Navigating follow-up care and medication after a private diagnosis has become a significant challenge. The Parliamentary and Health Service Ombudsman (PHSO) reports that NHS rules regarding who funds these prescriptions are unclear and inconsistent. This lack of clarity leads to Integrated Care Boards (ICBs) providing conflicting advice to patients.

Complaints concerning the NHS's treatment of ADHD and autism patients have tripled in the past five years. The PHSO emphasizes that patients should be upfront about potential out-of-pocket medication costs after private diagnosis to make informed decisions.

The proportion of ADHD prescriptions dispensed privately has risen significantly, from 2% to 12% between 2018-19 and 2023-24. An estimated 2.5 million people have ADHD in the UK, yet only about one in nine have received a diagnosis.

Issues with NHS commissioning and clarity extend beyond ADHD and autism, affecting areas like dentistry and wheelchair provision. This lack of consistent service and supply management prevents individuals from living economically productive lives and incurs unnecessary costs for the NHS and taxpayers.